ITGAV and neoplasm: Subsequently, nonglycosylated CSPG4 binds to ITGAV with the ECM to form the “differentiation niche.” ERK/MAPK signaling is upregulated via CSPG4–ITGAV–ECM complexes and induces GIC differentiation to promote tumor formation.